akampion´s executive management:

Ines-Regina Buth
 

• Formerly Head of Investor Relations at a transatlantic biopharmaceutical company (Micromet AG/ Micromet, Inc.), preparing an IPO and implementing the communication strategy for the reverse merger into a NASDAQ-listed company.
• Head of Investor Relations at a transatlantic bioinformatics company (LION bioscience AG) with a dual listing on Frankfurt Stock Exchange and NASDAQ .
• Investor Relations positions with two global blue chip companies (DaimlerChrysler AG, Schering AG). Project group member for Schering´s listing on New York Stock Exchange (NYSE).
• Member of the expert commission on Life Sciences at DVFA (German Association of Financial Analysts and Asset Managers), a group of industry professionals focusing on educating the financial markets about the Life Science sector and vice versa.
• First professional experience working in the corporate communications department at
  MLP AG and at Edelman Public Relations (corporate & financial communications).
• Master's Degree in Communication Management and North American Studies (FU Berlin, Germany); Certified Biotechnology Analyst, CBA (German Association of Financial Analysts and Asset Managers, DVFA).